logo
Select company
Select metric
$ 16.75MTotal Assets
VS
Market
8
Sector
17
Industry
20
History
30
$ 0.8Close
$ 0.68 - $ 2.3 52-Week Range
Ticker Information

Ticker

LGVN

Company Name

LONGEVERON INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LONGEVERON INC - Total Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LGVN - Assets Historical data
DateTotal Assets
6/30/2025$ 16.75M
3/31/2025$ 20.85M
12/31/2024$ 25.56M
9/30/2024$ 29.91M
6/30/2024$ 19.39M
3/31/2024$ 9.7M
12/31/2023$ 12.08M
9/30/2023$ 11.63M
6/30/2023$ 17.09M
3/31/2023$ 21.81M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LONGEVERON INC's latest trailing twelve months (TTM) Assets stands at $ 10.58M.
  • Over the past 5 years, LONGEVERON INC's average Assets has been $ 22.81M.
  • The median Assets for LONGEVERON INC during this period was $ 21.81M
  • LONGEVERON INC reached its highest Assets over the past 5 years at $ 42.77M.
  • The lowest Assets recorded by LONGEVERON INC in the same timeframe $ 9.24M

LONGEVERON INC's Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Assets Benchmarks
CompanyAssets
CYCN : CYCLERION THERAPEUTICS INC $ 9.37MTRAW : TRAWS PHARMA INC $ 15.62MLYRA : LYRA THERAPEUTICS INC $ 52.57MERNA : ERNEXA THERAPEUTICS INC $ 7.58MBRTX : BIORESTORATIVE THERAPIES INC $ 8.52MAPRE : APREA THERAPEUTICS INC $ 17.31MXBIO : XENETIC BIOSCIENCES INC $ 5.35MTXMD : THERAPEUTICSMD INC $ 38.5MLUCY : INNOVATIVE EYEWEAR INC $ 11.94MLEXX : LEXARIA BIOSCIENCE CORP $ 6.74M

Definition of Total Assets

[Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.

LGVN - Total Assets, Last 5 years

$ 9.24M

Minimum

Dec 31, 2020

$ 42.77M

Maximum

Dec 31, 2021

$ 22.81M

Average

$ 21.81M

Median

Assets Benchmark Analysis

The chart above depicts the distribution of Assets for companies in the Total Stock Market. The average Assets of the companies is $ 1.32B with a standard deviation of $ 1.71B.
The following table provides additional summary stats:
Assets in the Market:
filtered constituents3.48K
min$ 0
max$ 7.02B
average$ 1.32B
median$ 500.15M
std$ 1.71B